Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury

Arch Surg. 1992 Feb;127(2):159-62. doi: 10.1001/archsurg.1992.01420020041006.

Abstract

The incidence of opportunistic infections after thermal injury is high. Since 1985, we have been practicing Candida prophylaxis using nystatin "swish-and-swallow" and topical therapy. Patients treated between 1980 and 1984 served as controls and received no Candida prophylaxis. Although mean burn size, full-thickness injury, and age were comparable, the incidence of Candida colonization (26.7% vs 15.6%), infection (21.3% vs 10.0%), and sepsis (12.2% vs none) was significantly different between control and nystatin-treated groups, respectively. With prophylaxis, the incidence of Candida wound infection has been significantly reduced, and systemic candidiasis has been eradicated, eliminating the need for toxic systemic antifungal agents.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Buccal
  • Administration, Topical
  • Burns / complications*
  • Burns / mortality
  • Candidiasis / etiology
  • Candidiasis / mortality
  • Candidiasis / prevention & control*
  • Child
  • Child, Preschool
  • Fungemia / etiology
  • Fungemia / mortality
  • Fungemia / prevention & control*
  • Humans
  • Nystatin / administration & dosage
  • Nystatin / therapeutic use*
  • Retrospective Studies
  • Wound Infection / etiology
  • Wound Infection / prevention & control*

Substances

  • Nystatin